Replies to post #234891 on Biotech Values

[DewDiligence]

BMY-MYOK PR and CC slides…

https://finance.yahoo.com/news/bristol-myers-squibb-acquire-myokardia-103000720.html

https://s21.q4cdn.com/104148044/files/doc_presentations/2020/BMY-MYOK-Acquisition-Investor-Presentation.pdf

[DewDiligence]

BMY sells $7B of 3-30yr notes—to fund MYOK acquisition:

https://www.businesswire.com/news/home/20201109006199/en

• $1.5B of 3yr notes paying 0.537%
• $1.0B of 5yr notes paying 0.750%
• $1.0B of 7yr notes paying 1.125%
• $1.25B of 10yr notes paying 1.450%
• $0.75B of 20yr notes paying 2.350%
• $1.5B of 30yr notes paying 2.550%

At these rates, BMY should borrow as much as possible.

[DewDiligence]

BMY PDUFA date for Mavacamten is 1/28/22:

https://www.businesswire.com/news/home/20210319005189/en

Mavacamten is the drug BMY got in the $13.1B acquisition of MYOK in Oct 2020 (#msg-158698900).